Daiichi Life Group (TSE:8750) YoY EBITDA Growth: -4.05% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:8750 Daiichi Life Group Inc TSE:8750
67 GF Score
Price 円1,915.00
GF Value 円1,186.72
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Daiichi Life Group YoY EBITDA Growth?

Daiichi Life Group TSE:8750 +1.70% 67 YoY EBITDA Growth is -4.05% as of Mar. 2026. GuruFocus rates TSE:8750 with a GF Score™ of 67/100 and a GF Value™ of 円1,186.72 (Significantly Overvalued). The stock has 6 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Daiichi Life Group's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was -4.05%.

Daiichi Life Group's EBITDA per Share for the three months ended in Mar. 2026 was 円36.33.

Daiichi Life Group YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Daiichi Life Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daiichi Life Group YoY EBITDA Growth Chart

Daiichi Life Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.89 -29.71 49.57 47.54 8.01

Daiichi Life Group Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -54.84 62.06 40.64 -4.05 190.62
TSE:8750
67GF Score
Daiichi Life Group Inc TSE:8750
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daiichi Life Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Daiichi Life Group's YoY EBITDA Growth for the fiscal year that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (A: Mar. 2026 )
=(EBITDA per Share (A: Mar. 2026 )-EBITDA per Share (A: Mar. 2025 ))/ | EBITDA per Share (A: Mar. 2025 ) |
=(231.6-214.42)/ | 214.42 |
=8.01 %

Daiichi Life Group's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(36.334-37.869)/ | 37.869 |
=-4.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -4.05% mean?
Daiichi Life Group (TSE:8750) has a YoY EBITDA Growth of -4.05% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Daiichi Life Group and its competitors.
Is Daiichi Life Group's YoY EBITDA Growth too high?
Daiichi Life Group's current YoY EBITDA Growth is -4.05%. Overall, Daiichi Life Group has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Daiichi Life Group's YoY EBITDA Growth compare to MET and AFL?
Daiichi Life Group's YoY EBITDA Growth of -4.05% can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for an Insurance company?
A good YoY EBITDA Growth depends on the Insurance industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Daiichi Life Group and its competitors. Daiichi Life Group's current YoY EBITDA Growth is -4.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiichi Life Group stock overvalued right now?
Based on GuruFocus' analysis, Daiichi Life Group (TSE:8750) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,186.72, compared to a current price of 円1,915.00 — trading 61.4% above its estimated fair value. The current YoY EBITDA Growth is -4.05%. Daiichi Life Group's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Daiichi Life Group (TSE:8750), the current YoY EBITDA Growth is -4.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daiichi Life Group (TSE:8750) Overvalued in 2026?

Based on GuruFocus' analysis, Daiichi Life Group stock appears to be overvalued. The current stock price of 円1,915.00 is trading 61.4% above its estimated GF Value™ of 円1,186.72. GuruFocus considers Daiichi Life Group to be Significantly Overvalued.

Key valuation signals for TSE:8750:

  • YoY EBITDA Growth: -4.05%
  • GF Value™: 円1,186.72 vs. price of 円1,915.00 (61.4% above fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the TSE:8750 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daiichi Life Group Business Description

Address 13-1, Yurakucho 1-chome, Chiyoda-ku, Tokyo, JPN, 100-8411
Dai-ichi Life is Japan's second-largest life insurer (excluding the recently privatized Japan Post Insurance), commanding 11% of annualized net premiums. Unlike its largest domestic rivals—Nippon Life, Meiji Yasuda, and Sumitomo Life—which remain mutually owned by policyholders, Dai-ichi Life demutualized and listed on the Tokyo Stock Exchange in 2010. The group's profit profile is geographically diversified: The main domestic life business contributes roughly 75% of profits, the overseas life business contributes about 22%, and the noninsurance business contributes about 4% of total profits.
67GF Score

Get the complete analysis for TSE:8750

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,915.00
Price
円1,186.72
GF Value